Related Experiment Video
Updated: May 20, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Pulmonary cavity with black sputum in COVID-19-Pneumoconiosis: a case report
Wen-Qin Jiang1, Yu-Hong Li2, Wen-Ming Wang3
1Graduate School of Qinghai University, Xining, 810001, Qinghai, China.
Background:
Black sputum is scarce in clinical work. Pulmonary cavities with black sputum are more common in fungal infections and inhalation of a large amount of dust rarely.
Case Report:
A 58-year-old young man went to the hospital several times because of Black sputum after being infected with COVID-19 and was diagnosed with pulmonary tuberculosis. The chest computerized tomography (CT) showed multiple high-density mass shadows in both lungs, accompanied by cavity formation. Bronchoscopy showed carbon foam was deposited in bilateral bronchial mucosa without new organisms, and the bronchial lavage fluid is medium black mucus, which gene X-PERT/rifampicin resistance test, fungal and pathological examination were negative. According to medical history, the patient has been engaged in underground work in coal mines three times, without any preventive measures. The final diagnosis was pneumoconiosis. The symptoms were relieved after two alveolar lavage treatments within 1 month, and the black sputum disappeared. Chest CT showed lung cavity lesions are stable 3 months later.
Conclusion:
Occupational dust exposure should not be ignored when treating patients with hollow lungs and black sputum. Pneumoconiosis is always diagnosed at an advanced stage, either as a milia nodular disease in chest imaging, or it progresses to PMF (progressive bulk fibrotic), with or without cavitation. There are currently no reported cases of pneumoconiosis combined with COVID-19 infection. Patients with pneumoconiosis have become susceptible to COVID-19 infection due to pulmonary interstitial fibrosis and low immunity. PMF cases of COVID-19 are atypical, and their clinical symptoms, laboratory examinations, and imaging manifestations are allIt exhibits atypical properties, and because the fungal test is negative, infection with COVID-19 may accelerate the production of unexplained tracheal mucus and black sputum in microbiological examinations.
Related Concept Videos
Pneumothorax-II
Clinical Manifestations:
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumothorax-I
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

